<?xml version="1.0"?>
<rss version="2.0">
   <channel>
      <title>PM1B Revision - James Hall and Sarah Allman by James Hall</title>
      <link>https://padlet.com/dr_james_hall/z3mwp20fw20z</link>
      <description></description>
      <language>en-us</language>
      <pubDate>2019-04-26 09:24:48 UTC</pubDate>
      <lastBuildDate>2026-01-29 15:35:29 UTC</lastBuildDate>
      <webMaster>hello@padlet.com</webMaster>
      <image>
         <url></url>
      </image>
      <item>
         <title></title>
         <author>Dr_James_Hall</author>
         <link>https://padlet.com/dr_james_hall/z3mwp20fw20z/wish/354388884</link>
         <description><![CDATA[<div>Please feel free to post any questions here!</div>]]></description>
         <enclosure url="" />
         <pubDate>2019-04-26 09:32:12 UTC</pubDate>
         <guid>https://padlet.com/dr_james_hall/z3mwp20fw20z/wish/354388884</guid>
      </item>
      <item>
         <title></title>
         <author></author>
         <link>https://padlet.com/dr_james_hall/z3mwp20fw20z/wish/354510273</link>
         <description><![CDATA[<div>We'll check this Mondays, Wednesdays and Fridays</div>]]></description>
         <enclosure url="" />
         <pubDate>2019-04-26 16:09:39 UTC</pubDate>
         <guid>https://padlet.com/dr_james_hall/z3mwp20fw20z/wish/354510273</guid>
      </item>
      <item>
         <title></title>
         <author></author>
         <link>https://padlet.com/dr_james_hall/z3mwp20fw20z/wish/354719530</link>
         <description><![CDATA[<div>In the structure and function lectures it mentioned that in non competitive inhibition, substrate inhibition isn’t affected. Why is that so? When normally we learn that when an inhibitor binds on the enzyme elsewhere it changes the active site shape? <br><br>Thank you </div>]]></description>
         <enclosure url="" />
         <pubDate>2019-04-28 00:03:16 UTC</pubDate>
         <guid>https://padlet.com/dr_james_hall/z3mwp20fw20z/wish/354719530</guid>
      </item>
      <item>
         <title></title>
         <author>Dr_James_Hall</author>
         <link>https://padlet.com/dr_james_hall/z3mwp20fw20z/wish/354955921</link>
         <description><![CDATA[<div> </div><div>Hi <br><br></div><div>I am assuming that you meant to say that the “substrate binding” (rather than “substrate inhibition” isn’t affected? <br>If so then this is correct – the binding of the substrate is not affected by a non-competitive inhibitor. The inhibitor doesn’t change the overall shape of the enzyme and therefore the substrate can still bind. However, the inhibitor could work in a couple of different ways to prevent the enzymatic reaction from taking place. For example, the inhibitor could prevent the enzyme from undergoing a conformational change that is necessary for the reaction to occur. This doesn’t stop the substrate from binding but it would block the reaction. Hope this helps! </div><div><br></div><div>James <br><br></div>]]></description>
         <enclosure url="" />
         <pubDate>2019-04-29 11:32:42 UTC</pubDate>
         <guid>https://padlet.com/dr_james_hall/z3mwp20fw20z/wish/354955921</guid>
      </item>
      <item>
         <title></title>
         <author></author>
         <link>https://padlet.com/dr_james_hall/z3mwp20fw20z/wish/356835621</link>
         <description><![CDATA[<div>With regard to drug binding interactions at enzyme active sites, how can you differentiate between electrostatic interactions and dipole-dipole interactions - they both are important for initial binding, occur over long distances and both involve opposite charges attracting - Help please</div>]]></description>
         <pubDate>2019-05-04 15:15:22 UTC</pubDate>
         <guid>https://padlet.com/dr_james_hall/z3mwp20fw20z/wish/356835621</guid>
      </item>
      <item>
         <title></title>
         <author>Dr_James_Hall</author>
         <link>https://padlet.com/dr_james_hall/z3mwp20fw20z/wish/358855036</link>
         <description><![CDATA[<div>Hi there. I think you might be a little confused between ion-dipole and dipole-dipole interactions. The latter are weak interactions (compared to electrostatic or ion-dipole). If you look at slide 22 of lecture 1 you can see how the distance dependence changes for each interaction. For electrostatic interactions, if you double the distance you get half the intensity. For ion-dipole, if you double the distance you get a quarter of the intensity and for dipole-dipole, if you double the distance you divide the intensity by 8. </div>]]></description>
         <enclosure url="" />
         <pubDate>2019-05-10 13:03:14 UTC</pubDate>
         <guid>https://padlet.com/dr_james_hall/z3mwp20fw20z/wish/358855036</guid>
      </item>
      <item>
         <title></title>
         <author>Dr_James_Hall</author>
         <link>https://padlet.com/dr_james_hall/z3mwp20fw20z/wish/358856100</link>
         <description><![CDATA[<div>However one easy way to differentiate between electrostatic, ion-dipole and Van der Waals interactions is to look at the number and type of charges involved. For an electrostatic interaction you must have a positive charged group interacting with a negatively charged one. These must possess formal positive and negative charges. For ion-dipole, only one group needs a formal positive or negative charge, the other must possess a dipole. For dipole-dipole interactions, neither group will possess a full formal positive or negative charge.  <br><br></div>]]></description>
         <enclosure url="" />
         <pubDate>2019-05-10 13:05:49 UTC</pubDate>
         <guid>https://padlet.com/dr_james_hall/z3mwp20fw20z/wish/358856100</guid>
      </item>
      <item>
         <title></title>
         <author>Dr_James_Hall</author>
         <link>https://padlet.com/dr_james_hall/z3mwp20fw20z/wish/358856965</link>
         <description><![CDATA[<div>In any molecule, electrostatic interactions are those which are felt over the longest distance and are the most important for guiding the molecule to its target. However, this assumes that the molecule AND the active site have groups which have a positive or negative charge, which doesnt apply to all molecules or proteins. The second option is the ion-dipole, which is still felt over some distance but not as far as an electrostatic interaction. If the drug/target cannot support an electrostatic interaction then it is the ion-dipole interaction which drives that attraction.<br><br></div>]]></description>
         <enclosure url="" />
         <pubDate>2019-05-10 13:07:54 UTC</pubDate>
         <guid>https://padlet.com/dr_james_hall/z3mwp20fw20z/wish/358856965</guid>
      </item>
      <item>
         <title></title>
         <author>Dr_James_Hall</author>
         <link>https://padlet.com/dr_james_hall/z3mwp20fw20z/wish/358857246</link>
         <description><![CDATA[<div>In summary, both can drive the interaction but the electrostatic interaction is the strongest and most important IF the target and molecule can interact in that way<br><br></div>]]></description>
         <enclosure url="" />
         <pubDate>2019-05-10 13:08:34 UTC</pubDate>
         <guid>https://padlet.com/dr_james_hall/z3mwp20fw20z/wish/358857246</guid>
      </item>
   </channel>
</rss>
